Kritika Rehani

  First identified in Hubei province of Wuhan, China, this is the third time the coronavirus has created havoc in the whole world. Coronaviruses (CoV) are a large family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Known initially as novel coronavirus-2019 (nCoV-19), the virus has now been named Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses (ICTV), due to its genetic similarity with the coronavirus responsible for 2003 SARS outbreak.  It has already spread to more than 160 countries all over Asia, Europe, North America and the Middle East. More than 250k have been confirmed positive with SARS-CoV-2 as on March 20th, 2020. Looking at the rapid transmission of the infection and gravity of the situation, on 11th March 2020, the World Health Organization (WHO) declared the coronavir

  DelveInsight’s ‘ Athletes foot Market Insights, Epidemiology and Market Forecast-2030 ’ report delivers an in-depth understanding of the Athlete’s foot, historical and forecasted epidemiology as well as the Athlete’s foot market trends in the United States. The  Athlete’s foot market  report provides current treatment practices, emerging drugs, Athlete’s foot market share of the individual therapies, current and forecasted Athlete’s foot market Size from 2017 to 2030. The Report also covers current Athlete’s foot treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market. Geography Covered   • The United States Study Period: 2017–2030 Athlete’s foot Disease Understanding and Treatment Algorithm Athlete’s foot Overview Athlete's foot, also known as Tinea pedis, is a cutaneous fungal infection caused by a dermatophyte infection. It is characterized by itching, flaking, and

  Ankylosing spondylitis (AS) is a chronic immune-mediated inflammatory arthritis included in the group of spondyloarthritis (SpA). It is also called as Bechterew’s disease, a form of arthritis that primarily affects the spine, although other joints may also be involved. The disease causes inflammation of the spinal joints (vertebrae) that can lead to severe, chronic pain and discomfort. DelveInsight's " Ankylosing Spondylitis Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Ankylosing Spondylitis, historical and forecasted epidemiology as well as the Ankylosing Spondylitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Geography Covered ·         The United States ·         EU5 (Germany, France, Italy, Spain, and the United Kingdom) ·         Japan Study Period:   2017-2030 View report:  https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhte